Kathrin Scheckenbach Selected Research

Kathrin Scheckenbach Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 09/2002
15	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2005
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 11/2004
5	Hypersensitivity (Allergy) 05/2021 - 08/2012
4	Carcinoma (Carcinomatosis) 01/2021 - 11/2004
3	Oropharyngeal Neoplasms 12/2022 - 05/2010
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
3	Allergic Rhinitis 07/2013 - 06/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2021
2	COVID-19 09/2021 - 05/2021
2	Disease Progression 09/2021 - 05/2021
2	Body Weight (Weight, Body) 05/2021 - 02/2012
2	Fanconi Anemia (Fanconi's Anemia) 01/2018 - 02/2012
2	Rhinosinusitis 01/2017 - 01/2016
1	Radiodermatitis 01/2023
1	Dermatitis 01/2023
1	Infections 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Leukemia 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2021
1	Diabetes Mellitus 05/2021
1	Chronic Renal Insufficiency 05/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021
1	Transfusion Reaction 05/2021
1	Pneumonia (Pneumonitis) 05/2021
1	IgA Deficiency 05/2021
1	Pancreatitis 05/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Mouth Neoplasms (Oral Cancer) 08/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Nasal Polyps (Nasal Polyp) 01/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Mucositis 01/2016
1	Inflammation (Inflammations) 01/2016
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Seasonal Allergic Rhinitis (Hay Fever) 07/2013
1	Eosinophilia 07/2013
1	Sneezing 08/2012
1	Rhinorrhea 08/2012
1	Pruritus (Itching) 08/2012

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
5	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
4	AllergensIBA 01/2020 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2005
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2004
3	AntigensIBA 01/2022 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 09/2002
2	InterferonsIBA 01/2022 - 10/2019
2	AntibodiesIBA 05/2021 - 11/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2005
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2015
2	CytokinesIBA 01/2016 - 07/2013
2	ChemokinesIBA 06/2011 - 06/2009
2	Codon (Codons)IBA 02/2006 - 11/2004
1	Growth Factor ReceptorsIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	ElementsIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Single-Chain AntibodiesIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 09/2021
1	Chemokine ReceptorsIBA 09/2021
1	CC ChemokinesIBA 09/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2021
1	Oxygen (Dioxygen)IBA 05/2021
1	Capsules (Microcapsules)IBA 05/2021
1	camostatIBA 05/2021
1	romidepsin (FK228)FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	Immunoglobulin E (IgE)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2019
1	Long Noncoding RNAIBA 08/2019
1	CateninsIBA 01/2019
1	EnzymesIBA 01/2019
1	InflammasomesIBA 01/2016
1	MutagensIBA 09/2015
1	MicroRNAs (MicroRNA)IBA 03/2015
1	human MIRN214 microRNAIBA 03/2015
1	human MIRN452 microRNAIBA 03/2015
1	Chemokine CCL26IBA 07/2013
1	Interleukin-4 (Interleukin 4)IBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 07/2013
1	Interleukin-17 (Interleukin 17)IBA 07/2013

Therapy/Procedure

7	Immunotherapy 01/2022 - 10/2019
6	Radiotherapy 01/2023 - 12/2008
6	Therapeutics 12/2021 - 05/2010
5	Drug Therapy (Chemotherapy) 01/2023 - 12/2008
1	Re-Irradiation 01/2023
1	Microspheres (Microsphere) 01/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Contraindications 05/2021
1	Cannula 05/2021
1	Aftercare (After-Treatment) 01/2021
1	Chemoradiotherapy 01/2020
1	Laryngectomy 08/2014